Cheviot Value Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $122K | Hold |
2,125
| – | – | 0.01% | 159 |
|
|
2026
Q1 | $129K | Hold |
2,125
| – | – | 0.01% | 151 |
|
|
2025
Q4 | $116K | Hold |
2,125
| – | – | 0.01% | 157 |
|
|
2025
Q3 | $91K | Sell |
2,125
-2,000
| -48% | -$93.4K | 0.01% | 179 |
|
|
2025
Q2 | $190K | Hold |
4,125
| – | – | 0.02% | 118 |
|
|
2025
Q1 | $206K | Buy |
+4,125
| New | +$240K | 0.03% | 104 |
|
|
2023
Q4 | – | Sell |
-6,142
| Closed | -$356K | – | 74 |
|
|
2023
Q3 | $356K | Sell |
6,142
-340
| -5% | -$20.8K | 0.08% | 56 |
|
|
2023
Q2 | $415K | Sell |
6,482
-250
| -4% | -$16.8K | 0.09% | 54 |
|
|
2023
Q1 | $467K | Sell |
6,732
-26
| -0.4% | -$1.83K | 0.11% | 48 |
|
|
2022
Q4 | $486K | Hold |
6,758
| – | – | 0.12% | 47 |
|
|
2022
Q3 | $480K | Hold |
6,758
| – | – | 0.13% | 46 |
|
|
2022
Q2 | $520K | Hold |
6,758
| – | – | 0.13% | 49 |
|
|
2022
Q1 | $494K | Hold |
6,758
| – | – | 0.1% | 51 |
|
|
2021
Q4 | $421K | Hold |
6,758
| – | – | 0.1% | 53 |
|
|
2021
Q3 | $400K | Hold |
6,758
| – | – | 0.1% | 55 |
|
|
2021
Q2 | $452K | Hold |
6,758
| – | – | 0.11% | 55 |
|
|
2021
Q1 | $427K | Buy |
6,758
+3,300
| +95% | +$205K | 0.12% | 54 |
|
|
2020
Q4 | $214K | Hold |
3,458
| – | – | 0.06% | 62 |
|
|
2020
Q3 | $208K | Sell |
3,458
-224
| -6% | -$13.5K | 0.07% | 53 |
|
|
2020
Q2 | $217K | Hold |
3,682
| – | – | 0.08% | 56 |
|
|
2020
Q1 | $205K | Sell |
3,682
-300
| -8% | -$18.3K | 0.09% | 58 |
|
|
2019
Q4 | $256K | Hold |
3,982
| – | – | 0.1% | 65 |
|
|
2019
Q3 | $202K | Buy |
+3,982
| New | +$187K | 0.09% | 66 |
|
|
2019
Q1 | – | Sell |
-4,057
| Closed | -$211K | – | 59 |
|
|
2018
Q4 | $211K | Buy |
4,057
+465
| +13% | +$25K | 0.11% | 56 |
|
|
2018
Q3 | $223K | Buy |
+3,592
| New | +$213K | 0.1% | 63 |
|
|
2018
Q2 | – | Sell |
-3,592
| Closed | -$227K | – | 70 |
|
|
2018
Q1 | $227K | Sell |
3,592
-516
| -13% | -$33.2K | 0.12% | 60 |
|
|
2017
Q4 | $252K | Buy |
4,108
+741
| +22% | +$46.3K | 0.13% | 53 |
|
|
2017
Q3 | $215K | Sell |
3,367
-402
| -11% | -$23.5K | 0.12% | 50 |
|
|
2017
Q2 | $210K | Buy |
+3,769
| New | +$205K | 0.12% | 51 |
|
Other funds holding BMY
Cheviot Value Management's BMY Position: Q2 2026 in Review
Cheviot Value Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 2,125 shares worth $122K. The position accounts for 0.01% of the portfolio, ranked #159.
Cheviot Value Management first reported a position in BMY in Q2 2017 and has held it in 29 quarters since. The position peaked at $520K in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cheviot Value Management held 2,125 shares of Bristol-Myers Squibb worth $122K as of Q2 2026.
- Cheviot Value Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Cheviot Value Management's portfolio in Q2 2026, its #159 holding.
- Cheviot Value Management first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 29 quarters since.
- Cheviot Value Management's Bristol-Myers Squibb position peaked at $520K in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.